Literature DB >> 19255852

Prevalence of complicated gastroesophageal reflux disease and Barrett's esophagus among racial groups in a multi-center consortium.

Amy Wang1, Nora C Mattek, Jennifer L Holub, David A Lieberman, Glenn M Eisen.   

Abstract

AIMS: The Clinical Outcomes Research Initiative database was used to evaluate ethnic trends in complicated reflux disease and suspected Barrett's esophagus among various racial groups.
METHODS: Endoscopic findings for procedures performed January 2000-December 2005 for any indication and for reflux-related indications were reviewed by racial group.
RESULTS: Of 280,075 procedures examined, Hispanics were the most likely to have esophagitis (Hispanic 19.6%, white 17.3%, black 15.8%, Asian/Pacific Islander 9.5%, P-value<0.0001), and white subjects were most likely to have suspected BE (white 5.0%, Hispanic 2.9%, Asian/Pacific Islander 1.8%, black 1.5%, P-value<0.0001). Endoscopies performed for reflux-related indications had similar trends for esophagitis and esophageal stricture. Among reflux/Barrett's screening procedures adjusted for age and gender, Hispanics were most likely to have esophagitis (OR=1.28, P-value<0.0001) compared to Caucasians.
CONCLUSION: Our results demonstrate an association of suspected Barrett's esophagus and stricture with white patients and esophagitis with Hispanic patients. These findings need to be followed-up with further study.

Entities:  

Mesh:

Year:  2009        PMID: 19255852      PMCID: PMC3856566          DOI: 10.1007/s10620-009-0742-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  35 in total

1.  Colonization with cagA-positive Helicobacter pylori strains inversely associated with reflux esophagitis and Barrett's esophagus.

Authors:  R J Loffeld; B F Werdmuller; J G Kuster; G I Pérez-Pérez; M J Blaser; E J Kuipers
Journal:  Digestion       Date:  2000       Impact factor: 3.216

2.  Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group.

Authors:  J E Richter; W Bochenek
Journal:  Am J Gastroenterol       Date:  2000-11       Impact factor: 10.864

3.  Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus.

Authors:  Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

4.  Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus.

Authors:  Kenneth K Wang; Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2008-03       Impact factor: 10.864

5.  Obesity and estrogen as risk factors for gastroesophageal reflux symptoms.

Authors:  Magnus Nilsson; Roar Johnsen; Weimin Ye; Kristian Hveem; Jesper Lagergren
Journal:  JAMA       Date:  2003-07-02       Impact factor: 56.272

6.  Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and short of it all.

Authors:  Shanmugarajah Rajendra; Kannan Kutty; Norain Karim
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

7.  Racial differences in the frequency of symptoms and complications of gastro-oesophageal reflux disease.

Authors:  S J Spechler; S K Jain; D A Tendler; R A Parker
Journal:  Aliment Pharmacol Ther       Date:  2002-10       Impact factor: 8.171

8.  Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study.

Authors:  W M Wong; K C Lai; K F Lam; W M Hui; W H C Hu; C L K Lam; H H X Xia; J Q Huang; C K Chan; S K Lam; B C Y Wong
Journal:  Aliment Pharmacol Ther       Date:  2003-09-15       Impact factor: 8.171

9.  Gastroesophageal reflux among different racial groups in the United States.

Authors:  Hashem B El-Serag; Nancy J Petersen; Junaia Carter; David Y Graham; Peter Richardson; Robert M Genta; Linda Rabeneck
Journal:  Gastroenterology       Date:  2004-06       Impact factor: 22.682

10.  Prevalence of Barrett's esophagus in an urban Korean population: a multicenter study.

Authors:  Jung Il Lee; Hyojin Park; Hwoon-Yong Jung; Poong-Lyul Rhee; Chi Wook Song; Myung Gyu Choi
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

View more
  21 in total

1.  Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium.

Authors:  Prateek Sharma; David A Katzka; Neil Gupta; Jaffer Ajani; Navtej Buttar; Amitabh Chak; Douglas Corley; Hashem El-Serag; Gary W Falk; Rebecca Fitzgerald; John Goldblum; Frank Gress; David H Ilson; John M Inadomi; Ernest J Kuipers; John P Lynch; Frank McKeon; David Metz; Pankaj J Pasricha; Oliver Pech; Richard Peek; Jeffrey H Peters; Alessandro Repici; Stefan Seewald; Nicholas J Shaheen; Rhonda F Souza; Stuart J Spechler; Prashanth Vennalaganti; Kenneth Wang
Journal:  Gastroenterology       Date:  2015-08-19       Impact factor: 22.682

2.  African Americans with Barrett's esophagus are less likely to have dysplasia at biopsy.

Authors:  Joe E Khoury; Sian Chisholm; M Mazen Jamal; Carlos Palacio; Sunitha Pudhota; Kenneth J Vega
Journal:  Dig Dis Sci       Date:  2011-09-11       Impact factor: 3.199

3.  GERD in Minority Populations.

Authors:  Frank K Friedenberg
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-06

4.  Sex and race and/or ethnicity differences in patients undergoing radiofrequency ablation for Barrett's esophagus: results from the U.S. RFA Registry.

Authors:  Sarina Pasricha; Nan Li; William J Bulsiewicz; Richard I Rothstein; Anthony Infantolino; Atilla Ertan; Daniel S Camara; Evan S Dellon; George Triadafilopoulos; Charles J Lightdale; Ryan D Madanick; William D Lyday; Raman V Muthusamy; Bergein F Overholt; Nicholas J Shaheen
Journal:  Gastrointest Endosc       Date:  2015-04-01       Impact factor: 9.427

5.  Low Prevalence of Suspected Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease Without Alarm Symptoms.

Authors:  Emery C Lin; Jennifer Holub; David Lieberman; Chin Hur
Journal:  Clin Gastroenterol Hepatol       Date:  2018-09-07       Impact factor: 11.382

6.  Racial Disparity in the Sex Distribution, the Prevalence, and the Incidence of Dysplasia in Barrett's Esophagus.

Authors:  Prashanthi N Thota; Shamiq Zackria; Madhusudhan R Sanaka; Deepa Patil; John Goldblum; Rocio Lopez; Amitabh Chak
Journal:  J Clin Gastroenterol       Date:  2017 May/Jun       Impact factor: 3.062

Review 7.  Environmental - lifestyle related factors.

Authors:  Sabine Roman; John E Pandolfino
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-12       Impact factor: 3.043

Review 8.  The integrity of the esophageal mucosa. Balance between offensive and defensive mechanisms.

Authors:  Roy C Orlando
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-12       Impact factor: 3.043

9.  The frequency of histologically confirmed Barrett's esophagus varies by the combination of ethnicity and gender.

Authors:  Sian S Chisholm; Joe E Khoury; M Mazen Jamal; Carlos Palacio; Sunitha Pudhota; Kenneth J Vega
Journal:  J Gastrointest Oncol       Date:  2017-02

10.  Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005.

Authors:  M B Cook; W-H Chow; S S Devesa
Journal:  Br J Cancer       Date:  2009-08-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.